Does RISANKIZUMAB-RZAA Cause Erythema? 1,051 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,051 reports of Erythema have been filed in association with RISANKIZUMAB-RZAA. This represents 1.6% of all adverse event reports for RISANKIZUMAB-RZAA.
1,051
Reports of Erythema with RISANKIZUMAB-RZAA
1.6%
of all RISANKIZUMAB-RZAA reports
2
Deaths
136
Hospitalizations
How Dangerous Is Erythema From RISANKIZUMAB-RZAA?
Of the 1,051 reports, 2 (0.2%) resulted in death, 136 (12.9%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 1,051 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Erythema?
ADAPALENE (38,965)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (30,872)
DUPILUMAB (10,877)
ADALIMUMAB (4,829)
ETANERCEPT (3,733)
AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (3,462)
INFLIXIMAB (2,919)
METHOTREXATE (2,835)
SECUKINUMAB (2,824)
RITUXIMAB (2,460)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Erythema Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA